BioPharma & Healthcare Related News

Mammoth Diagnostics to Develop New Diagnostic Tests Using Oligo Pools from Twist Bioscience

Palo Alto, Calif. – September 12, 2017 – Mammoth Diagnostics today announced that it will purchase oligo pools from Twist Bioscience to develop a new class of sequence-based diagnostics. “Using comprehensive oligo pools from Twist Bioscience, we are able to [...]

By | September 23rd, 2017|BioPharma & Healthcare, News|

Synthetic Biology and Immunotherapy to Bring More Effective Cell Therapies for Cancer

For years, the foundations of cancer treatment were chemotherapy, surgery, and radiation therapy. But over the past several years, progress with therapies that collect and use a patient’s own immune cells to attack tumors (in other words, immunotherapy) have greatly [...]

By | September 22nd, 2017|BioPharma & Healthcare, News, Therapeutics|

Oxitec to Build State-of-the-Art Mosquito Egg Production Unit

UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendly™ Aedes Mosquito Eggs per Week OXFORD, UK September, 19, 2017 – Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON), today announced plans to [...]

By | September 21st, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Meet Jacob Glanville, a scientist and entrepreneur pioneering the next generation of biomedicine

This week we interviewed Jacob Glanville, a computational immunoengineer who co-founded Distributed Bio, a company focused on applying computationally-guided immunoengineering methods to enable a new generation of monoclonal antibody discovery and universal vaccine design. He applies his hybrid expertise in [...]

By | September 19th, 2017|BioPharma & Healthcare, News, Therapeutics|

Berkeley Lights Announces Strategic Project with Bayer Focused on Cell Line Development and Antibody Discovery

Beacon™ OptoFluidic Platform to Automate Workflows for Greater Efficiencies Emeryville, CA – September 12, 2017 – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, today announced a strategic project with Bayer AG, Germany (Bayer), [...]

By | September 18th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Horizon Discovery announces launch of Genome-Wide CRISPRi and CRISPRa Screening Services

Cambridge, UK, 18 September 2017: Horizon Discovery (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announces that it has expanded its functional genomic screening portfolio to include first-to-market CRISPRi (interference) and CRISPRa [...]

By | September 18th, 2017|BioPharma & Healthcare, News, Therapeutics|